289 related articles for article (PubMed ID: 19352366)
1. Development trends for therapeutic antibody fragments.
Nelson AL; Reichert JM
Nat Biotechnol; 2009 Apr; 27(4):331-7. PubMed ID: 19352366
[No Abstract] [Full Text] [Related]
2. Drug discovery alliances.
Jones A; Clifford L
Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845
[No Abstract] [Full Text] [Related]
3. Mastering medicinal chemistry: strategies, issues and success stories.
Lindsley CW
Drug Discov Today; 2004 Aug; 9(16):695-6. PubMed ID: 15341782
[No Abstract] [Full Text] [Related]
4. The end of the beginning?
Nat Rev Drug Discov; 2006 Sep; 5(9):705. PubMed ID: 17001798
[No Abstract] [Full Text] [Related]
5. Looking forward in pharmaceutical process chemistry.
Davies IW; Welch CJ
Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
[TBL] [Abstract][Full Text] [Related]
6. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
Schirlin D; Galvan M; Le Fur G
Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
[TBL] [Abstract][Full Text] [Related]
7. Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologies.
Chartrain M; Chu L
Curr Pharm Biotechnol; 2008 Dec; 9(6):447-67. PubMed ID: 19075685
[TBL] [Abstract][Full Text] [Related]
8. Trends in the development of chiral drugs.
Caner H; Groner E; Levy L; Agranat I
Drug Discov Today; 2004 Feb; 9(3):105-10. PubMed ID: 15038394
[No Abstract] [Full Text] [Related]
9. Tailor-made antibody therapeutics.
Chowdhury PS; Wu H
Methods; 2005 May; 36(1):11-24. PubMed ID: 15848071
[TBL] [Abstract][Full Text] [Related]
10. Top ten hot topics in parenteral science and technology.
Akers MJ; Nail SL; Saffell-Clemmer W
PDA J Pharm Sci Technol; 2007; 61(5):337-61. PubMed ID: 18047174
[TBL] [Abstract][Full Text] [Related]
11. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
12. Antibody Engineering & Design 2010. 24-25 February 2010, Frankfurt, Germany.
Beck A
IDrugs; 2010 May; 13(5):295-9. PubMed ID: 20432182
[TBL] [Abstract][Full Text] [Related]
13. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody successes in the clinic.
Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
[TBL] [Abstract][Full Text] [Related]
15. Advances in solid dosage form manufacturing technology.
Andrews GP
Philos Trans A Math Phys Eng Sci; 2007 Dec; 365(1861):2935-49. PubMed ID: 17855217
[TBL] [Abstract][Full Text] [Related]
16. [Biologics--the new horizon for medical therapy].
Ziegenhagen DJ
Versicherungsmedizin; 2009 Mar; 61(1):4-9. PubMed ID: 19370838
[TBL] [Abstract][Full Text] [Related]
17. Venturing into drug discovery.
Steinmetz M
Nat Biotechnol; 1998 May; 16 Suppl():17. PubMed ID: 9591255
[No Abstract] [Full Text] [Related]
18. Continuous flow reactors for drug discovery.
Watts P; Haswell SJ
Drug Discov Today; 2003 Jul; 8(13):586-93. PubMed ID: 12850334
[TBL] [Abstract][Full Text] [Related]
19. Value of pharmaceutical sciences.
Borchardt RT
Pharm Res; 1997 Aug; 14(8):958-66. PubMed ID: 9279873
[No Abstract] [Full Text] [Related]
20. Nanobodies.
Gibbs WW
Sci Am; 2005 Aug; 293(2):78-83. PubMed ID: 16053141
[No Abstract] [Full Text] [Related]
[Next] [New Search]
